世界のCOPD用治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global COPD Medication Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5675
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、COPD用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（短時間作用型気管支拡張薬、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張薬、併用薬）、用途別市場規模（病院、診療所、薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・COPD用治療薬の市場動向
・企業の競争状況、市場シェア
・COPD用治療薬の種類別市場規模と予測2016-2027（短時間作用型気管支拡張薬、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張薬、併用薬）
・COPD用治療薬の用途別市場規模と予測2016-2027（病院、診療所、薬局、オンライン薬局）
・COPD用治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・COPD用治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・COPD用治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・COPD用治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・COPD用治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche、Novartis、GSK、Teva、AstraZeneca、Boehringer Ingelheim、Nephron Pharmaceuticals）
・結論

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It’s typically caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke.

Market Analysis and Insights: Global COPD Medication Market
The global COPD Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COPD Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COPD Medication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COPD Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COPD Medication market.

Global COPD Medication Scope and Market Size
COPD Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COPD Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Short-Acting Bronchodilator
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Combination Drugs

Segment by Application
Hospital
Clinic
Pharmacy
Online Pharmacy

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Novartis
GSK
Teva
AstraZeneca
Boehringer Ingelheim
Nephron Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Short-Acting Bronchodilator
1.2.3 Corticosteroids
1.2.4 Methylxanthines
1.2.5 Long-Acting Bronchodilators
1.2.6 Combination Drugs
1.3 Market by Application
1.3.1 Global COPD Medication Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global COPD Medication Market Perspective (2016-2027)
2.2 COPD Medication Growth Trends by Regions
2.2.1 COPD Medication Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 COPD Medication Historic Market Share by Regions (2016-2021)
2.2.3 COPD Medication Forecasted Market Size by Regions (2022-2027)
2.3 COPD Medication Industry Dynamic
2.3.1 COPD Medication Market Trends
2.3.2 COPD Medication Market Drivers
2.3.3 COPD Medication Market Challenges
2.3.4 COPD Medication Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top COPD Medication Players by Revenue
3.1.1 Global Top COPD Medication Players by Revenue (2016-2021)
3.1.2 Global COPD Medication Revenue Market Share by Players (2016-2021)
3.2 Global COPD Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COPD Medication Revenue
3.4 Global COPD Medication Market Concentration Ratio
3.4.1 Global COPD Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Medication Revenue in 2020
3.5 COPD Medication Key Players Head office and Area Served
3.6 Key Players COPD Medication Product Solution and Service
3.7 Date of Enter into COPD Medication Market
3.8 Mergers & Acquisitions, Expansion Plans

4 COPD Medication Breakdown Data by Type
4.1 Global COPD Medication Historic Market Size by Type (2016-2021)
4.2 Global COPD Medication Forecasted Market Size by Type (2022-2027)

5 COPD Medication Breakdown Data by Application
5.1 Global COPD Medication Historic Market Size by Application (2016-2021)
5.2 Global COPD Medication Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America COPD Medication Market Size (2016-2027)
6.2 North America COPD Medication Market Size by Type
6.2.1 North America COPD Medication Market Size by Type (2016-2021)
6.2.2 North America COPD Medication Market Size by Type (2022-2027)
6.2.3 North America COPD Medication Market Size by Type (2016-2027)
6.3 North America COPD Medication Market Size by Application
6.3.1 North America COPD Medication Market Size by Application (2016-2021)
6.3.2 North America COPD Medication Market Size by Application (2022-2027)
6.3.3 North America COPD Medication Market Size by Application (2016-2027)
6.4 North America COPD Medication Market Size by Country
6.4.1 North America COPD Medication Market Size by Country (2016-2021)
6.4.2 North America COPD Medication Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe COPD Medication Market Size (2016-2027)
7.2 Europe COPD Medication Market Size by Type
7.2.1 Europe COPD Medication Market Size by Type (2016-2021)
7.2.2 Europe COPD Medication Market Size by Type (2022-2027)
7.2.3 Europe COPD Medication Market Size by Type (2016-2027)
7.3 Europe COPD Medication Market Size by Application
7.3.1 Europe COPD Medication Market Size by Application (2016-2021)
7.3.2 Europe COPD Medication Market Size by Application (2022-2027)
7.3.3 Europe COPD Medication Market Size by Application (2016-2027)
7.4 Europe COPD Medication Market Size by Country
7.4.1 Europe COPD Medication Market Size by Country (2016-2021)
7.4.2 Europe COPD Medication Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific COPD Medication Market Size (2016-2027)
8.2 Asia-Pacific COPD Medication Market Size by Type
8.2.1 Asia-Pacific COPD Medication Market Size by Type (2016-2021)
8.2.2 Asia-Pacific COPD Medication Market Size by Type (2022-2027)
8.2.3 Asia-Pacific COPD Medication Market Size by Type (2016-2027)
8.3 Asia-Pacific COPD Medication Market Size by Application
8.3.1 Asia-Pacific COPD Medication Market Size by Application (2016-2021)
8.3.2 Asia-Pacific COPD Medication Market Size by Application (2022-2027)
8.3.3 Asia-Pacific COPD Medication Market Size by Application (2016-2027)
8.4 Asia-Pacific COPD Medication Market Size by Region
8.4.1 Asia-Pacific COPD Medication Market Size by Region (2016-2021)
8.4.2 Asia-Pacific COPD Medication Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America COPD Medication Market Size (2016-2027)
9.2 Latin America COPD Medication Market Size by Type
9.2.1 Latin America COPD Medication Market Size by Type (2016-2021)
9.2.2 Latin America COPD Medication Market Size by Type (2022-2027)
9.2.3 Latin America COPD Medication Market Size by Type (2016-2027)
9.3 Latin America COPD Medication Market Size by Application
9.3.1 Latin America COPD Medication Market Size by Application (2016-2021)
9.3.2 Latin America COPD Medication Market Size by Application (2022-2027)
9.3.3 Latin America COPD Medication Market Size by Application (2016-2027)
9.4 Latin America COPD Medication Market Size by Country
9.4.1 Latin America COPD Medication Market Size by Country (2016-2021)
9.4.2 Latin America COPD Medication Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa COPD Medication Market Size (2016-2027)
10.2 Middle East & Africa COPD Medication Market Size by Type
10.2.1 Middle East & Africa COPD Medication Market Size by Type (2016-2021)
10.2.2 Middle East & Africa COPD Medication Market Size by Type (2022-2027)
10.2.3 Middle East & Africa COPD Medication Market Size by Type (2016-2027)
10.3 Middle East & Africa COPD Medication Market Size by Application
10.3.1 Middle East & Africa COPD Medication Market Size by Application (2016-2021)
10.3.2 Middle East & Africa COPD Medication Market Size by Application (2022-2027)
10.3.3 Middle East & Africa COPD Medication Market Size by Application (2016-2027)
10.4 Middle East & Africa COPD Medication Market Size by Country
10.4.1 Middle East & Africa COPD Medication Market Size by Country (2016-2021)
10.4.2 Middle East & Africa COPD Medication Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche COPD Medication Introduction
11.1.4 Roche Revenue in COPD Medication Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis COPD Medication Introduction
11.2.4 Novartis Revenue in COPD Medication Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK COPD Medication Introduction
11.3.4 GSK Revenue in COPD Medication Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva COPD Medication Introduction
11.4.4 Teva Revenue in COPD Medication Business (2016-2021)
11.4.5 Teva Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca COPD Medication Introduction
11.5.4 AstraZeneca Revenue in COPD Medication Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim COPD Medication Introduction
11.6.4 Boehringer Ingelheim Revenue in COPD Medication Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Nephron Pharmaceuticals
11.7.1 Nephron Pharmaceuticals Company Details
11.7.2 Nephron Pharmaceuticals Business Overview
11.7.3 Nephron Pharmaceuticals COPD Medication Introduction
11.7.4 Nephron Pharmaceuticals Revenue in COPD Medication Business (2016-2021)
11.7.5 Nephron Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global COPD Medication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Short-Acting Bronchodilator
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Methylxanthines
Table 5. Key Players of Long-Acting Bronchodilators
Table 6. Key Players of Combination Drugs
Table 7. Global COPD Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global COPD Medication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global COPD Medication Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global COPD Medication Market Share by Regions (2016-2021)
Table 11. Global COPD Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global COPD Medication Market Share by Regions (2022-2027)
Table 13. COPD Medication Market Trends
Table 14. COPD Medication Market Drivers
Table 15. COPD Medication Market Challenges
Table 16. COPD Medication Market Restraints
Table 17. Global COPD Medication Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global COPD Medication Market Share by Players (2016-2021)
Table 19. Global Top COPD Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Medication as of 2020)
Table 20. Ranking of Global Top COPD Medication Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by COPD Medication Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players COPD Medication Product Solution and Service
Table 24. Date of Enter into COPD Medication Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COPD Medication Market Size by Type (2016-2021) (US$ Million)
Table 27. Global COPD Medication Revenue Market Share by Type (2016-2021)
Table 28. Global COPD Medication Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global COPD Medication Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global COPD Medication Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global COPD Medication Revenue Market Share by Application (2016-2021)
Table 32. Global COPD Medication Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global COPD Medication Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America COPD Medication Market Size by Type (2016-2021) (US$ Million)
Table 35. North America COPD Medication Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America COPD Medication Market Size by Application (2016-2021) (US$ Million)
Table 37. North America COPD Medication Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America COPD Medication Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America COPD Medication Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe COPD Medication Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe COPD Medication Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe COPD Medication Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe COPD Medication Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe COPD Medication Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe COPD Medication Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific COPD Medication Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific COPD Medication Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific COPD Medication Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific COPD Medication Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific COPD Medication Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific COPD Medication Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America COPD Medication Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America COPD Medication Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America COPD Medication Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America COPD Medication Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America COPD Medication Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America COPD Medication Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa COPD Medication Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa COPD Medication Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa COPD Medication Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa COPD Medication Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa COPD Medication Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa COPD Medication Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche COPD Medication Product
Table 67. Roche Revenue in COPD Medication Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis COPD Medication Product
Table 72. Novartis Revenue in COPD Medication Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK COPD Medication Product
Table 77. GSK Revenue in COPD Medication Business (2016-2021) & (US$ Million)
Table 78. GSK Recent Development
Table 79. Teva Company Details
Table 80. Teva Business Overview
Table 81. Teva COPD Medication Product
Table 82. Teva Revenue in COPD Medication Business (2016-2021) & (US$ Million)
Table 83. Teva Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca COPD Medication Product
Table 87. AstraZeneca Revenue in COPD Medication Business (2016-2021) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Boehringer Ingelheim Company Details
Table 90. Boehringer Ingelheim Business Overview
Table 91. Boehringer Ingelheim COPD Medication Product
Table 92. Boehringer Ingelheim Revenue in COPD Medication Business (2016-2021) & (US$ Million)
Table 93. Boehringer Ingelheim Recent Development
Table 94. Nephron Pharmaceuticals Company Details
Table 95. Nephron Pharmaceuticals Business Overview
Table 96. Nephron Pharmaceuticals COPD Medication Product
Table 97. Nephron Pharmaceuticals Revenue in COPD Medication Business (2016-2021) & (US$ Million)
Table 98. Nephron Pharmaceuticals Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COPD Medication Market Share by Type: 2020 VS 2027
Figure 2. Short-Acting Bronchodilator Features
Figure 3. Corticosteroids Features
Figure 4. Methylxanthines Features
Figure 5. Long-Acting Bronchodilators Features
Figure 6. Combination Drugs Features
Figure 7. Global COPD Medication Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Pharmacy Case Studies
Figure 11. Online Pharmacy Case Studies
Figure 12. COPD Medication Report Years Considered
Figure 13. Global COPD Medication Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global COPD Medication Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global COPD Medication Market Share by Regions: 2020 VS 2027
Figure 16. Global COPD Medication Market Share by Regions (2022-2027)
Figure 17. Global COPD Medication Market Share by Players in 2020
Figure 18. Global Top COPD Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Medication as of 2020
Figure 19. The Top 10 and 5 Players Market Share by COPD Medication Revenue in 2020
Figure 20. Global COPD Medication Revenue Market Share by Type (2016-2021)
Figure 21. Global COPD Medication Revenue Market Share by Type (2022-2027)
Figure 22. North America COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America COPD Medication Market Share by Type (2016-2027)
Figure 24. North America COPD Medication Market Share by Application (2016-2027)
Figure 25. North America COPD Medication Market Share by Country (2016-2027)
Figure 26. United States COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe COPD Medication Market Share by Type (2016-2027)
Figure 30. Europe COPD Medication Market Share by Application (2016-2027)
Figure 31. Europe COPD Medication Market Share by Country (2016-2027)
Figure 32. Germany COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific COPD Medication Market Share by Type (2016-2027)
Figure 40. Asia-Pacific COPD Medication Market Share by Application (2016-2027)
Figure 41. Asia-Pacific COPD Medication Market Share by Region (2016-2027)
Figure 42. China COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America COPD Medication Market Share by Type (2016-2027)
Figure 50. Latin America COPD Medication Market Share by Application (2016-2027)
Figure 51. Latin America COPD Medication Market Share by Country (2016-2027)
Figure 52. Mexico COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa COPD Medication Market Share by Type (2016-2027)
Figure 56. Middle East & Africa COPD Medication Market Share by Application (2016-2027)
Figure 57. Middle East & Africa COPD Medication Market Share by Country (2016-2027)
Figure 58. Turkey COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Roche Revenue Growth Rate in COPD Medication Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in COPD Medication Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in COPD Medication Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in COPD Medication Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in COPD Medication Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in COPD Medication Business (2016-2021)
Figure 67. Nephron Pharmaceuticals Revenue Growth Rate in COPD Medication Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の喘息/COPD併用薬市場規模・現状・予測（2021年-2027年）

Global Asthma/COPD Combination Medication Market Size, Status and Forecast 2021-2027
QFJ1-5601 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、喘息/COPD併用薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブデソニド、LAMA / LABAコンボ、フルチカゾン/サルメテロール）、用途別市場規模（中等度COPD、重度COPD、喘息）、主要...

世界のCOPD治療薬市場規模・現状・予測（2021年-2027年）

Global COPD Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5676 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、COPD治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、吸入コルチコステロイド、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の抗喘息薬＆COPD薬市場規模・現状・予測（2021年-2027年）

Global Anti-Asthmatics and COPD Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3819 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、抗喘息薬＆COPD薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、モノクローナル抗体、併用薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧...

世界の投薬＆包装システム市場規模・現状・予測（2021年-2027年）

Global Medication Dispensing and Packaging Systems Market Size, Status and Forecast 2021-2027
QFJ1-4485 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、投薬＆包装システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キャニスター100個以下、101〜300個、キャニスター300個以上）、用途別市場規模（小売薬局、病院薬局、介護薬局）、主要地域別市場...

世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年）

Global Injectable Pain Medication Market Size, Status and Forecast 2021-2027
QFJ1-4373 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、注射式鎮痛薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬（NSAID）、中枢作用性鎮痛薬）、用途別市場規模（病院、クリニック、リカバリーセンター）、主要地域別市場規模（北米、...

世界の安全投薬用遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Genetic Testing for Safe Medication Market Size, Status and Forecast 2021-2027
QFJ1-4254 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、安全投薬用遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（口腔粘膜コレクション、FTA血液サンプルコレクション）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の心筋症治療薬市場規模・現状・予測（2021年-2027年）

Global Cardiomyopathy Medication Market Size, Status and Forecast 2021-2027
QFJ1-3973 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、心筋症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗凝固剤、抗不整脈剤、抗高血圧剤、心筋配糖体、その他）、用途別市場規模（病院、診療所、ホームケア、その他）、主要地域別市場規模（北米、アメリ...

世界の慢性閉塞性肺疾患（COPD）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4015 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、慢性閉塞性肺疾患（COPD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、ホスホジエステラーゼ4型阻害剤、気管支拡張剤、その他）、用途別市場規模（病院、診療所、小売薬局、その...

世界のペット用医薬品市場規模・現状・予測（2021年-2027年）

Global Pet Medication Market Size, Status and Forecast 2021-2027
QFJ1-5942 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、ペット用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗真菌剤、ノミ製品）、用途別市場規模（猫、犬、馬、魚、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の抗糖尿病薬市場規模・現状・予測（2021年-2027年）

Global Anti-diabetic Medication Market Size, Status and Forecast 2021-2027
QFJ1-5584 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、抗糖尿病薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、その他）、用途別市場規模（糖尿病予防・治療、肥満治療、心臓血管保護、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の喘息/COPD併用薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Asthma/COPD Combination Medication Market The global Asthma/COPD Combination Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界の長時間作用型インスリン市場規模・現状・予測（2021年-2027年） Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of d…
世界のCOPD治療薬市場規模・現状・予測（2021年-2027年） Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of …
世界の抗喘息薬＆COPD薬市場規模・現状・予測（2021年-2027年） The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The cla…
世界の長時間作用型注射薬市場規模・現状・予測（2021年-2027年） Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdo…